Fahriye T. Kos - Publications

Survival Outcomes in ERBB2-Low vs ERBB2-Null Advanced Gastric Cancer.

Journal: JAMA network open

Published: July 21, 2026

Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: May 06, 2026

Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial.

Journal: European urology

Published: February 24, 2026

Nailfold capillaroscopy findings after anthracycline-based chemotherapy and their association with subclinical changes in left ventricular ejection fraction.

Journal: BMC cancer

Published: November 24, 2025

Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Journal: Discover oncology

Published: October 10, 2025

Adjuvant nivolumab vs pembrolizumab in stage IIB/IIC melanoma: a reinforcement learning-based simulation study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 10, 2025

The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: September 08, 2025

Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancer.

Journal: Expert review of anticancer therapy

Published: August 30, 2025

The predictive value of sarcopenia and PET imaging metrics in metastatic non-squamous NSCLC.

Journal: Biomarkers in medicine

Published: August 03, 2025

Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: July 24, 2025

Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort.

Journal: Medicina (Kaunas, Lithuania)

Published: March 10, 2025

A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score.

Journal: Current oncology (Toronto, Ont.)

Published: February 09, 2025